A novel ultra-sensitive method for the detection of FGFR3 mutations in urine of bladder cancer patients – Design of the Urodiag® PCR kit for surveillance of patients with non-muscle-invasive bladder cancer (NMIBC)

We have recently developed a highly accurate urine-based test, named Urodiag ®, associating FGFR3 mutation and DNA methylation assays for recurrence surveillance in patients with low-, intermediate-, and high-risk...
Source: BMC Medical Genetics - Category: Genetics & Stem Cells Authors: Tags: Technical advance Source Type: research